Avalo Therapeutics
AVTX
AVTX
18 hedge funds and large institutions have $73.5M invested in Avalo Therapeutics in 2018 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
0% more first-time investments, than exits
New positions opened: 6 | Existing positions closed: 6
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
18
Holding in Top 10
1
Calls
$4K
Puts
–
Top Buyers
| 1 | +$1.58M | |
| 2 | +$327K | |
| 3 | +$288K | |
| 4 |
BlackRock
New York
|
+$108K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$64K |
Top Sellers
| 1 | -$1.11M | |
| 2 | -$334K | |
| 3 | -$229K | |
| 4 |
VF
Virtu Financial
New York
|
-$103K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$86K |